
|Articles|September 1, 2009
Gene-directed therapy in glaucoma may have future clinical applications
Application of genetic knowledge holds huge potential for the future and some believe that it has potential to become larger than the pharmaceutical market. Here Dr Alward examines what it has offered for the understanding and future treatment of glaucoma. Until recently, breakthroughs in glaucoma genetics emerged from painstaking family research, with the discovery of LOXL1 being the exception.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Ophthalmic care uncommon after tamoxifen initiation
2
Global Summit for Eye Health 2026: Turning pledges into eye care
3
October 2026 retina recap: Duravyu stumbles, DAYBREAK delivers, and optogenetics takes the Nobel
4
Empire Forum 2026: Ambati on K8 phase 2 results in geographic atrophy
5












